At Alcon, we are driven by the meaningful work we do to help people see brilliantly. We innovate boldly, champion progress, and act with speed as the global leader in eye care. Here, you’ll be recognized
Background Sanofi has decided to invest in new, state-of-the-art production facilities for the entire insulin portfolio as part of the InsuLINK program, to ensure a future-oriented, sustainable, and reliable long-term supply for diabetes patients worldwide. Beijing,
Background Sanofi has decided to invest into new large state-of-the art facilities for the full portfolio for insulin Drug Substances to ensure future oriented, sustainable, reliable and leading-edge long-term supply for world-wide Diabetes patients. The new
Background Sanofi has decided to invest into new large state-of-the art facilities for the full portfolio for insulin Drug Substances to ensure future oriented, sustainable, reliable and leading-edge long-term supply for world-wide Diabetes patients. The new